Share this postINSIDE PHARMAGSK has a track record—not of the good kind, the very, very bad kindCopy linkFacebookEmailNotesMoreGSK has a track record—not of the good kind, the very, very bad kindCheck out the 'controversies'Hedley ReesJan 03, 2024∙ Paid10Share this postINSIDE PHARMAGSK has a track record—not of the good kind, the very, very bad kindCopy linkFacebookEmailNotesMoreShareSubscribeCheck this out, GSK ‘controversies’This post is for paid subscribersSubscribeAlready a paid subscriber? Sign in